The COVID-19 vaccine developed by Johnson & Johnson has been discovered to be effective against the extremely infectious Delta coronavirus variant, according to a new study published on Thursday.
“Current data for the eight months studied so far show that the single-shot Johnson & Johnson COVID-19 vaccine generates a strong neutralizing antibody response that does not wane; rather, we observe an improvement over time. In addition, we observe a persistent and particularly robust, durable cellular immune response,” concluded Janssen Research & Development Head, Mathai Mammen.
A joint working session took place this Thursday evening at the headquarters of the Ministry…
A specialized brigade of the National Guard in Sousse was able to apprehend a woman…
The Center for Research in Astronomy, Astrophysics and Geophysics in Algeria registeredthis evening, Thursday, May…
A citizen from the town of Al Kalaa Kobra confirmed that his mother was surprised…
Palestinian President Mahmoud Abbas accused, in his address today before the Arab summit in Manama,…
Palestinian President Mahmoud Abbas stated that American support for Israel "calls into question international legitimacy…
This website uses cookies.